Where does Mahendra G. Shah work?

Mahendra G. Shah is General Partner at Vivo Panda and Advisor at Vivo Capital and Board director at Crinetics Pharmaceuticals.

What check size does Mahendra G. Shah write?

Mahendra G. Shah typically writes checks of $10M – $50M.

What companies has Mahendra G. Shah invested in?

Investments tracked here include Cerebral Therapeutics, Homology Medicines.

Mahendra G. Shah

Investor

General Partner at Vivo Panda · Advisor at Vivo Capital · Board director at Crinetics Pharmaceuticals · Director at Cerebral Therapeutics

San Francisco Bay Area

Writes $10M – $50M checks · typically $25M

Find your path to Mahendra

78 people in our graph can introduce you to Mahendra.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Michael Wood to introduce you to Mahendra

You →Michael · together at Crinetics Pharmaceuticals →Mahendra

Ask Jamie Chen to introduce you to Mahendra

You →Jamie · together at Vivo Panda →Mahendra

Ask Sam Okafor to introduce you to Mahendra

You →Sam · 5 people · together at Crinetics Pharmaceuticals →Mahendra

Your email: the people you already email who know Mahendra
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Mahendra
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Pharmaceutical entrepreneur and former longtime Vivo Capital member (15+ years) who transitioned into an advisor role. Founder of Semnur Pharmaceuticals and former CEO of NextWave and First Horizon Pharmaceuticals; holds a Ph.D. from St. John's University.

Contact· self-published, not guessed

mshah@vivocapital.com

Board director at Crinetics Pharmaceuticals

Intro paths

→

In turn, Mahendra can intro founders to Crinetics Pharmaceuticals's investors below.

Crinetics Pharmaceuticals's investors · 6

5AM VenturesSan Francisco · $100K – $4M checks Foresite CapitalWest Hollywood National Institutes of Health (NIH)since 2015 OrbiMedNew York · $1M – $75M checks RA CapitalBoston Vivo CapitalPalo Alto · $10M – $50M checks · since 2018

Co-founders at Crinetics Pharmaceuticals

Richard Scott StruthersExecutive Officer, Director

Stephen BetzChief Scientific Officer

Director at Cerebral Therapeutics

Intro paths

→

In turn, Mahendra can intro founders to Cerebral Therapeutics's investors below.

Cerebral Therapeutics's investors · 4

Granite Point Capitalsince 2020 March Capital PartnersSanta Monica · since 2020 RA CapitalBoston · since 2020 Vivo CapitalPalo Alto · $10M – $50M checks · since 2020

Investments

Investor

Cerebral Therapeutics Homology Medicines

Per curated public sources.

Leave your own feedback

Colleagues at Vivo Panda

Michael Chang

Managing Partner at Vivo Capital

Frequently asked questions

Who is Mahendra G. Shah?: Pharmaceutical entrepreneur and former longtime Vivo Capital member (15+ years) who transitioned into an advisor role. Founder of Semnur Pharmaceuticals and former CEO of NextWave and First Horizon Pharmaceuticals; holds a Ph.D. from St. John's University.
Where does Mahendra G. Shah work?: Mahendra G. Shah is General Partner at Vivo Panda and Advisor at Vivo Capital and Board director at Crinetics Pharmaceuticals.
What check size does Mahendra G. Shah write?: Mahendra G. Shah typically writes checks of $10M – $50M.
What companies has Mahendra G. Shah invested in?: Investments tracked here include Cerebral Therapeutics, Homology Medicines.